BeOne Medicines (ONC) Shareholder's Equity Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.62% |
| Dec 31, 2025 | -0.17% |
| Sep 30, 2025 | -3.92% |
| Jun 30, 2025 | -10.14% |
| Mar 31, 2025 | -15.37% |
| Dec 31, 2024 | -18.40% |
| Sep 30, 2024 | 0.78% |
| Jun 30, 2024 | -2.27% |
| Mar 31, 2024 | -5.67% |
| Dec 31, 2023 | -2.95% |
| Sep 30, 2023 | -4.25% |
| Jun 30, 2023 | 14.26% |
| Mar 31, 2023 | 13.72% |
| Dec 31, 2022 | 64.86% |
| Sep 30, 2022 | 53.22% |
| Jun 30, 2022 | 48.99% |
| Mar 31, 2022 | 52.67% |
| Dec 31, 2021 | 51.79% |
| Sep 30, 2021 | 19.17% |
| Jun 30, 2021 | 43.26% |
| Mar 31, 2021 | 43.36% |
| Dec 31, 2020 | 78.16% |
| Sep 30, 2020 | 78.79% |
| Jun 30, 2020 | 111.24% |
| Mar 31, 2020 | 109.28% |
| Dec 31, 2019 | 40.48% |
| Sep 30, 2019 | 90.29% |
| Jun 30, 2019 | 92.57% |
| Mar 31, 2019 | 88.29% |
| Dec 31, 2018 | 167.92% |